CND Life Sciences

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, CND Life Sciences sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).

8 total trials 3 currently recruiting 1 completed upper quartile by trial count

CND Life Sciences: 8 sponsored US clinical trials, 3 recruiting.

CND Life Sciences sponsors 8 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Parkinson Disease, with 4 trials.

Upper-quartile sponsor footprint

CND Life Sciences sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

8 total, page 1 of 1

RECRUITING

Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease

NCT07428447
RECRUITING

Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder

NCT07217054
RECRUITING

Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis

NCT07204652
ACTIVE NOT RECRUITING

Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's Disease

NCT06621602
ACTIVE NOT RECRUITING

Long COVID-19 Cutaneous Signatures: An ARPA Funded Research Project

NCT07005947
ACTIVE NOT RECRUITING

The Syn-Sleep Study

NCT05757206
ACTIVE NOT RECRUITING

A Diagnostic Test for Dementia With Lewy Bodies

NCT05479552
COMPLETED

Synuclein-One Study

NCT04700722

Therapeutic Areas

Parkinson Disease 4
Parkinson 2
PARKINSON DISEASE (Disorder) 2
REM Sleep Behavior Disorder (iRBD) 1
Acute COVID-19 1
REM Behavior Disorder 1
MCI-DLB, Early Stage Dementia With Lewy Bodies 1
MCI-AD, Early Stage Alzheimer's Disease 1
Essential Tremor-plus 1
Essential Tremor, Movement Disorders 1

What is open in the CND Life Sciences pipeline

3 recruiting of 8 indexed (38% open); 1 completed (13%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Parkinson Disease (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

CND Life Sciences: open-pipeline peers nationwide

Peers matched on 8 registered trials and 38% open enrollment, not the therapeutic-area sidebar.

CND Life Sciences sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 8.088.1 0%10%20%30%40% Total trials Recruiting share CND Life SciencesAB ScienceAbbott Point of CareAbeona TherapeuticsAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)American Thrombosis and Hemostasis NetworkAskBioAthletic Greens InternationalBanner Health
CND Life Sciences sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

CND Life Sciences sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 8 trials (± recruiting share)

Sponsors near 38% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this CND Life Sciences page

8 registered trials is a research-attention snapshot, not an endorsement of CND Life Sciences or any single study.

  • 3 of CND Life Sciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Parkinson Disease is the condition CND Life Sciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Parkinson Disease trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. CND Life Sciences pipeline card: 8 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.